Combination Products Reservation. Novavax shall not, directly or indirectly, (i) engage in, promote, or finance the research, development, or commercialization of, or (ii) grant any license, or any similar rights with respect to, to a Third Party, in each case of (i) and (ii), a Licensed Product in combination with another active ingredient, antigen or adjuvant in the Territory.
Appears in 5 contracts
Samples: H1n1 License Agreement (Novavax Inc), Option Agreement (Novavax Inc), Option Agreement (Novavax Inc)